Condition
Age Related Macular Degeneration (ARMD) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Age Related Macular Degeneration (ARMD) clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Australia (1), New Zealand (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
ABF-101 single and multiple ascending dose safety test in healthy adults and people with AMD
This study will test whether ABF-101 is safe, well tolerated, and how it behaves in the body in healthy adults and in people with age-related macular degeneration.
-
Microcurrent therapy for advanced age-related macular degeneration
This study is testing a new device that uses microcurrents to see if it can improve vision and eye health in people with advanced age-related macular degeneration.
Related topics
Quick answers
How many Age Related Macular Degeneration (ARMD) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Australia (1 trial), New Zealand (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.